Real-world Persistency, Effectiveness, and Safety Among Patients with NMOSD Treated with Inebilizumab (20250110)

08/04/2026
08/04/2026
EU PAS number:
EUPAS1000000958
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol-Published Original inebilizumab-cdon 20250110 .pdf

English (1.91 MB - PDF) View document
Study results
Study report
Other information